Author:
Marschall Andrea L. J.,Dübel Stefan,Böldicke Thomas
Publisher
Springer International Publishing
Reference94 articles.
1. Alvarez RD, Barnes MN, Gomez-Navarro J, Wang M, Strong TV, Arafat W, Arani RB, Johnson MR, Roberts BL, Siegal GP, Curiel DT (2000) A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Clin Cancer Res 6(8):3081–3087
2. Arafat W, Gomez-Navarro J, Xiang J, Siegal GP, Alvarez RD, Curiel DT (2000) Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target. Cancer Gene Ther 7(9):1250–1256
3. Beerli RR, Wels W, Hynes NE (1994) Autocrine inhibition of the epidermal growth factor receptor by intracellular expression of a single-chain antibody. Biochem Biophys Res Commun 204(2):666–672
4. Beerli RR, Wels W, Hynes NE (1994) Intracellular expression of single chain antibodies reverts ErbB-2 transformation. J Biol Chem 269(39):23931–23936
5. Beerli RR, Wels W, Hynes NE (1996) Inhibition of signaling from Type 1 receptor tyrosine kinases via intracellular expression of single-chain antibodies. Breast Cancer Res Treat 38(1):11–17